AAHI scientists were recently awarded a project agreement through the Medical CBRN Defense Consortium (MCDC) Other Transaction Authority (OTA) to develop a prototype itnranasal bivalent influenza RNA vaccine candidate that targets both pandemic A(H5N1) and A(…